Lars Rebien Sørensen, who chairs the Novo Nordisk Foundation, will join its board as an observer while the company seeks a ...

Novo Nordisk A/S NVO shares lost 2.7% on Friday after a surprising announcement regarding changes to its executive leadership ...

"The changes are made in light of the recent market challenges Novo Nordisk has been facing, and the development of the ...

Jørgensen will step down after eight years as CEO, with a successor search underway while the company reaffirms confidence in ...

Despite early success, however, Novo Nordisk has fallen behind in the GLP-1RA race, overtaken by Eli Lilly and its GLP-1RA ...

Per the press release, Lars Fruergaard Jørgensen will step down as CEO of Novo Nordisk following a mutual agreement with the company's board. He will remain in the role for a transitional period ...

CEO Lars Fruergaard Jørgensen will step down after eight years at the helm of the Danish pharmaceutical giant responsible for ...

Novo Nordisk is ending CEO Lars Fruergaard Jørgensen’s 34 ... with Jørgensen remaining in his role for a transitional period.

Shares of Novo Nordisk (NYSE: NVO) fell 3% today following the announcement that CEO Lars Fruergaard Jørgensen will step down ...